Treatment Strategies in Endogenous Fungal Endophthalmitis - Quiz - MDSpire

Treatment Strategies in Endogenous Fungal Endophthalmitis

Management of endogenous fungal endophthalmitis is complex, with wide variation in treatment strategies. Systemic markers of disease appear to influence the choice of initial therapy more than ocular findings. Although no definitive evidence favors IV over oral systemic therapy, a comprehensive, multidisciplinary approach that considers ocular involvement is essential to optimize patient outcomes in EFE.

  • By

  • Arthi Venkat, MD, MS

  • Eleanor M. Burton, MD

  • January 1, 2026

  • 7 min

Share

Original Source(s)

Treatment Strategies in Endogenous Fungal Endophthalmitis

  • by Arthi Venkat, MD, MS, Eleanor M. Burton, MD

  • January 1, 2026

Related Content

GLP-1RAs Linked to Reduced Uveitis Risk

A large cohort study suggests uveitis risk is lower in patients taking GLP-1 receptor agonists, compared to other antihyperglycemic drugs.

Clinical Trial Update May/June 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

  • May 1, 2026

  • 44 min
Imaging Leukocyte Dynamics in Retinal Disease

The movement of immune cells through the retinal vasculature has long been inferred from laboratory models. Now, advances in imaging are allowing clinicians to observe these processes directly. At the 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Denver, Richard B. Rosen, MD, ScD(hon), FACS, FASRS, FARVO, described early clinical work using adaptive optics scanning laser ophthalmoscopy (AOSLO) to visualize leukocyte trafficking in vivo.